Absci Corporation
NASDAQ:ABSI
Overview | Financials
Company Name | Absci Corporation |
Symbol | ABSI |
Currency | USD |
Price | 3.01 |
Market Cap | 345,716,560 |
Dividend Yield | 0% |
52-week-range | 2.45 - 6.72 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sean McClain |
Website | https://www.absci.com |
An error occurred while fetching data.
About Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD